{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:47Z","timestamp":1793140727414,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00702-018-1913-1","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T12:13:09Z","timestamp":1534248789000},"page":"1403-1415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Mariza","family":"Bortolanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauce C.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio B.","family":"Socias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ploper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana N.","family":"Cheh\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Raisman-Vozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Del-Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/0253-7613.93841","volume":"44","author":"R Agnihotri","year":"2012","unstructured":"Agnihotri R, Gaur S (2012) Chemically modified tetracyclines: novel therapeutic agents in the management of chronic periodontitis. Indian J Pharmacol 44:161\u2013167. \n                    https:\/\/doi.org\/10.4103\/0253-7613.93841","journal-title":"Indian J Pharmacol"},{"issue":"25","key":"1913_CR2","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1073\/pnas.0600554103","volume":"103","author":"CC Alano","year":"2006","unstructured":"Alano CC, Kauppinen TM, Valls AV, Swanson RA (2006) Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103(25):9685\u20139690. \n                    https:\/\/doi.org\/10.1073\/pnas.0600554103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"1913_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-5793(97)00605-4","volume":"410","author":"AR Amin","year":"1997","unstructured":"Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB (1997) Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410(2\u20133):259\u2013264. \n                    https:\/\/doi.org\/10.1016\/S0014-5793(97)00605-4","journal-title":"FEBS Lett"},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4023","volume":"12","author":"PA Andreux","year":"2013","unstructured":"Andreux PA, Houtkooper RH, Auwerx J (2013) Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 12:465\u2013483. \n                    https:\/\/doi.org\/10.1038\/nrd4023","journal-title":"Nat Rev Drug Discov"},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1067\/mjd.2002.120448","volume":"46","author":"JSM Archer","year":"2002","unstructured":"Archer JSM, Archer DF (2002) Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 46:917\u2013923. \n                    https:\/\/doi.org\/10.1067\/mjd.2002.120448","journal-title":"J Am Acad Dermatol"},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683. \n                    https:\/\/doi.org\/10.1038\/nrd1468","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1913_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/138955712798868977","volume":"12","author":"F Bahrami","year":"2012","unstructured":"Bahrami F, Morris DL, Pourgholami MH (2012) Tetracyclines: drugs with huge therapeutic potential. Mini Rev Med Chem 12(1):44\u201352. \n                    https:\/\/doi.org\/10.2174\/138955712798868977","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"1913_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","volume":"16","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Willemsen AT, Doorduin J, de Vries EF, Dierckx RA, Leenders KL (2010) [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease? Parkinsonism Relat Disord 16(1):57\u201359. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.05.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1913_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7150\/ijbs.5617","volume":"9","author":"F Bi","year":"2013","unstructured":"Bi F, Li F, Huang C, Zhou H (2013) Pathogenic mutation in VPS35 impairs its protection against MPP(+) cytotoxicity. Int J Biol Sci 9(2):149\u2013155. \n                    https:\/\/doi.org\/10.7150\/ijbs.5617","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1913_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","volume":"17","author":"D Blum","year":"2004","unstructured":"Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M (2004) Clinical potential of minocycline for neurodegenerative disorders, Neurobiol Dis 17(3):359\u2013366. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2004.07.012","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1913_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","volume":"19","author":"RM Bonelli","year":"2004","unstructured":"Bonelli RM, H\u00f6dl AK, Hofmann P, Kapfhammer HP (2004) Neuroprotection in Huntington\u2019s disease: a 2-year study on minocycline. Int Clin Psychopharmacol 19(6):337\u2013342","journal-title":"Int Clin Psychopharmacol"},{"issue":"10","key":"1913_CR12","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1021\/jm900291j","volume":"52","author":"S Bourgault","year":"2009","unstructured":"Bourgault S, Vaudry D, S\u00e9galas-Milazzo I, Guilhaudis L, Couvineau A, Laburthe M, Vaudry H, Fournier A (2009) Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. J Med Chem 52(10):3308\u20133316. \n                    https:\/\/doi.org\/10.1021\/jm900291j","journal-title":"J Med Chem"},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"BD Bradaric","year":"2012","unstructured":"Bradaric BD, Patel A, Schneider JA, Carvey PM, Hendey B (2012) Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm 119:59\u201371","journal-title":"J Neural Transm"},{"issue":"8","key":"1913_CR14","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, Mao X, Shin JH, Lee Y, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Ko HS (2016) Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein-induced neurodegeneration. J Clin Invest 126(8):2970\u20132988. \n                    https:\/\/doi.org\/10.1172\/JCI85456","journal-title":"J Clin Invest"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1085-5629(03)00046-4","volume":"22","author":"EL Carter","year":"2003","unstructured":"Carter EL (2003) Antibiotics in Cutaneous medicine: an update. Semin Cutan Med Surg 22:196\u2013211. \n                    https:\/\/doi.org\/10.1016\/S1085-5629(03)00046-4","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"1913_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","volume":"97","author":"MJ Casarejos","year":"2006","unstructured":"Casarejos MJ, Men\u00e9ndez J, Solano RM, Rodr\u00edguez-Navarro JA, Garc\u00eda de Y\u00e9benes J, Mena MA (2006) Susceptibility to rotenone is increased in neurons from parkin null mice is reduced by minocycline. J Neurochem 97(4):934\u2013946. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03777.x","journal-title":"J Neurochem"},{"key":"1913_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.2741\/4365","volume":"20","author":"JM Cathcart","year":"2015","unstructured":"Cathcart JM, Cao J (2015) MMP inhibitors: past, present and future. Front Biosci (Landmark Ed) 20:1164\u20131178","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"1913_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bph.13798","volume":"175","author":"Y Cha","year":"2018","unstructured":"Cha Y, Erez T, Reynolds IJ, Kumar D, Ross J, Koytiger G, Kusko R, Zeskind B, Risso S, Kagan E, Papapetropoulos S, Grossman I, Laifenfeld D (2018) Drug repurposing from the perspective of pharmaceutical companies. Br J Pharmacol 175(2):168\u2013180. \n                    https:\/\/doi.org\/10.1111\/bph.13798","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1913_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/77528","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6(7):797\u2013801. \n                    https:\/\/doi.org\/10.1038\/77528","journal-title":"Nat Med"},{"issue":"8","key":"1913_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60(8):1059\u20131064. \n                    https:\/\/doi.org\/10.1001\/archneur.60.8.1059","journal-title":"Arch Neurol"},{"issue":"4","key":"1913_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12640-009-9078-1","volume":"16","author":"Y Cho","year":"2009","unstructured":"Cho Y, Son HJ, Kim EM, Choi JH, Kim ST, Ji IJ, Choi DH, Joh TH, Kim YS, Hwang O (2009) Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3. Neurotox Res 16(4):361\u2013371. \n                    https:\/\/doi.org\/10.1007\/s12640-009-9078-1","journal-title":"Neurotox Res"},{"issue":"2","key":"1913_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3340\/jkns.2011.49.2.83","volume":"49","author":"DC Cho","year":"2011","unstructured":"Cho DC, Cheong JH, Yang MS, Hwang SJ, Kim JM, Kim CH (2011) The effect of minocy clineon motor neuron recovery and neuropathic pain in a rat model of spinal cord injury. J Korean Neurosurg Soc 49(2):83\u201391. \n                    https:\/\/doi.org\/10.3340\/jkns.2011.49.2.83","journal-title":"J Korean Neurosurg Soc"},{"key":"1913_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232\u2013260. \n                    https:\/\/doi.org\/10.1128\/MMBR.65.2.232-260.2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"1913_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/156720107781023938","volume":"4","author":"I Chopra","year":"2007","unstructured":"Chopra I, Hawkey PM, Hinton M, Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N, Galindo MF (2007) Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr Drug Deliv 4(3):225\u2013331","journal-title":"Curr Drug Deliv"},{"issue":"4","key":"1913_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10637-006-9031-6","volume":"25","author":"QS Chu","year":"2007","unstructured":"Chu QS, Forouzesh B, Syed S, Mita M, Schwartz G, Cooper J, Curtright J, Rowinsky EK (2007) A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas. Invest New Drugs 25(4):359\u2013367. \n                    https:\/\/doi.org\/10.1007\/s10637-006-9031-6","journal-title":"Invest New Drugs"},{"issue":"1","key":"1913_CR27","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I et al (2013) Triggering of inflammasome by aggregated a\u2013Synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8(1):e55375. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS ONE"},{"key":"1913_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0006-291X(65)90954-X","volume":"20","author":"RH Connamacher","year":"1965","unstructured":"Connamacher RH, Mandel HG (1965) Binding of tetracycline to the 30S ribosomes and to polyuridylic acid. Biochem Biophys Res Comm 20:98\u2013103","journal-title":"Biochem Biophys Res Comm"},{"issue":"9","key":"1913_CR30","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ophtha.2010.01.037","volume":"117","author":"CA Cox","year":"2010","unstructured":"Cox CA, Amaral J, Salloum R, Guedez L, Reid TW, Jaworski C, John- Aryankalayil M, Freedman KA, Campos MM, Martinez A, Becerra SP, Carper DA (2010) Doxycycline\u2019s effect on ocular angiogenesis: an in vivo analysis. Ophthalmology 117(9):1782\u20131791","journal-title":"Ophthalmology"},{"key":"1913_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1749-6632.1994.tb24738.x","volume":"732","author":"YA DeClerck","year":"1994","unstructured":"DeClerck YA, Shimada H, Taylor SM, Langley KE (1994) Matrix metalloproteinases and their inhibitors in tumor progression. Ann NY Acad Sci 732:222\u2013232. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1994.tb24738.x","journal-title":"Ann NY Acad Sci"},{"issue":"9","key":"1913_CR32","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","volume":"24","author":"BJ Dezube","year":"2006","unstructured":"Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24(9):1389\u20131394. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.04.2614","journal-title":"J Clin Oncol"},{"issue":"1","key":"1913_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2004.05.016","volume":"189","author":"E Diguet","year":"2004","unstructured":"Diguet E, Gross CE, Tison F, Bezard E (2004) Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp Neurol 189(1):1\u20134. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2004.05.016","journal-title":"Exp Neurol"},{"issue":"1","key":"1913_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mds.22732","volume":"25","author":"R Dodel","year":"2010","unstructured":"Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N et al (2010) Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 25(1):97\u2013107. \n                    https:\/\/doi.org\/10.1002\/mds.22732","journal-title":"Mov Disord"},{"issue":"12","key":"1913_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2004.10.001","volume":"25","author":"M Domercq","year":"2004","unstructured":"Domercq M, Matute C (2004) Neuroprotection by tetracyclines. Trends Pharmacol Sci 25(12):609\u2013612. \n                    https:\/\/doi.org\/10.1016\/j.tips.2004.10.001","journal-title":"Trends Pharmacol Sci"},{"issue":"25","key":"1913_CR36","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR et al (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98(25):14669\u201314674. \n                    https:\/\/doi.org\/10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Art. 2","key":"1913_CR37","doi-asserted-by":"publisher","first-page":"177181","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","volume":"51","author":"BM Duggar","year":"1948","unstructured":"Duggar BM (1948) Aureomycin: a product of the continuing search for new antibiotics. Ann N Y Acad Sci 51(Art. 2):177\u2013181. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1948.tb27262.x","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1913_CR38","doi-asserted-by":"publisher","first-page":"e57827","DOI":"10.1371\/journal.pone.0057827","volume":"8","author":"RA Edan","year":"2013","unstructured":"Edan RA, Luqmani YA, Masocha W (2013) COL-3, a chemically modified tetracycline, inhibits lipopolysaccharide-induced microglia activation and cytokine expression in the brain. PLoS ONE 8(2):e57827. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0057827","journal-title":"PLoS ONE"},{"issue":"5","key":"1913_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","volume":"73","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH, Thyssen JP (2016) Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study. JAMA Neurol 73(5):529\u2013534. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.0022","journal-title":"JAMA Neurol"},{"issue":"10","key":"1913_CR40","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/archderm.1984.01650460048018","volume":"120","author":"NB Esterly","year":"1984","unstructured":"Esterly NB, Koransky JS, Furey NL, Trevisan M (1984) Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 120(10):1308\u20131313. \n                    https:\/\/doi.org\/10.1001\/archderm.1984.01650460048018","journal-title":"Arch Dermatol"},{"issue":"2","key":"1913_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.21453","volume":"64","author":"S Fahn","year":"2008","unstructured":"Fahn S (2008) How do you treat motor complications in Parkinson\u2019s disease: medicine, surgery, or both? Ann Neurol 64(2):56\u201364. \n                    https:\/\/doi.org\/10.1002\/ana.21453","journal-title":"Ann Neurol"},{"key":"1913_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2202-10-109","volume":"10","author":"K Faust","year":"2009","unstructured":"Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson\u2019s disease. BMC Neurosci 10:109. \n                    https:\/\/doi.org\/10.1186\/1471-2202-10-109","journal-title":"BMC Neurosci"},{"issue":"12","key":"1913_CR43","first-page":"14601467","volume":"2003","author":"B Fingleton","year":"2003","unstructured":"Fingleton B (2003) CMT-3. CollaGenex. Curr Opin Investig Drugs 2003(12):1460\u20131467","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"1913_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1871526510909010023","volume":"9","author":"G Forloni","year":"2009","unstructured":"Forloni G, Salmona M, Marcon G, Tagliavini F (2009) Tetracyclines and prion infectivity. Infect Disord Drug Targets 9(1):23\u201330. \n                    https:\/\/doi.org\/10.2174\/1871526510909010023","journal-title":"Infect Disord Drug Targets"},{"key":"1913_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1326-4-47","volume":"4","author":"TC Frank-Cannon","year":"2009","unstructured":"Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4:47. \n                    https:\/\/doi.org\/10.1186\/1750-1326-4-47","journal-title":"Mol Neurodegener"},{"key":"1913_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00002281-199803000-00007","volume":"10","author":"DE Furst","year":"1998","unstructured":"Furst DE (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Curr Opin Rheumatol 10:123\u2013128","journal-title":"Curr Opin Rheumatol"},{"key":"1913_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-0765.1991.tb01626.x","volume":"26","author":"WL Gabler","year":"1991","unstructured":"Gabler WL, Creamer HR (1991) Suppression of human neutrophil functions by tetracycline. J Periodontal Res 26:52\u201358. \n                    https:\/\/doi.org\/10.1111\/j.1600-0765.1991.tb01626.x","journal-title":"J Periodontal Res"},{"key":"1913_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29:357\u2013365. \n                    https:\/\/doi.org\/10.1016\/j.it.2008.05.002","journal-title":"Trends Immunol"},{"key":"1913_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bcp.2009.07.028","volume":"79","author":"EM Garcia-Martinez","year":"2010","unstructured":"Garcia-Martinez EM, Sanz-Blasco S, Karachitos A, Bandez MJ, Fernandez-Gomez FJ, Perez-Alvarez S, De Mera RM, Jordan MJ, Aguirre N, Galindo MF, Villalobos C, Navarro A, Kmita H, Jordan J (2010) Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem Pharmacol 79:239\u2013250. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2009.07.028","journal-title":"Biochem Pharmacol"},{"key":"1913_CR50","doi-asserted-by":"publisher","first-page":"CD002086","DOI":"10.1002\/14651858.CD002086","volume":"8","author":"SE Garner","year":"2003","unstructured":"Garner SE, Eady EA, Popescu C, Newton J, Li WA (2003) Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 8:CD002086. \n                    https:\/\/doi.org\/10.1002\/14651858.CD002086","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1913_CR01","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/10454411910020030201","volume":"2","author":"LM Golub","year":"1991","unstructured":"Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2(3):297\u2013321","journal-title":"Crit Rev Oral Biol Med"},{"key":"1913_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/0972-124X.149934","volume":"2","author":"LM Golub","year":"1992","unstructured":"Golub LM, Soummalainen K, Sorsa T (1992) Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 2:80\u201390. \n                    https:\/\/doi.org\/10.4103\/0972-124X.149934","journal-title":"Curr Opin Dent"},{"key":"1913_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/08959374980120010501","volume":"12","author":"LM Golub","year":"1998","unstructured":"Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12\u201326. \n                    https:\/\/doi.org\/10.1177\/08959374980120010501","journal-title":"Adv Dent Res"},{"key":"1913_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07691.x","volume":"878","author":"LM Golub","year":"1999","unstructured":"Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, Bain S, Sorsa T (1999) A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann N Y Acad Sci 878:290\u2013310. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07691.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1913_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/idj.12221","volume":"66","author":"LM Golub","year":"2016","unstructured":"Golub LM, Elburki MS, Walker C, Ryan M, Sorsa T, Tenenbaum H, Goldberg M, Wolff M, Gu Y (2016) Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. Int Dent J 66(3):127\u2013135. \n                    https:\/\/doi.org\/10.1111\/idj.12221","journal-title":"Int Dent J"},{"issue":"2","key":"1913_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/08959374980120010501","volume":"33","author":"LL Gompels","year":"2006","unstructured":"Gompels LL, Smith A, Charles PJ, Rogers W, Soon-Shiong J, Mitchell A et al (2006) Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis. J Rheumatol 33(2):224\u2013227. \n                    https:\/\/doi.org\/10.1177\/08959374980120010501","journal-title":"J Rheumatol"},{"key":"1913_CR56","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1038\/srep41755","volume":"7","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F, Soc\u00edas SB, \u00c1vila CL, Torres-Bugeau CM, Barbosa LR, Binolfi A, Sep\u00falveda-D\u00edaz JE, Del-Bel E, Fernandez CO, Papy-Garcia D, Itri R, Raisman-Vozari R, Cheh\u00edn RN (2017) Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci Rep 7:41755. \n                    https:\/\/doi.org\/10.1038\/srep41755","journal-title":"Sci Rep"},{"issue":"12","key":"1913_CR57","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","volume":"6","author":"PH Gordon","year":"2007","unstructured":"Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C et al (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6(12):1045\u20131053. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(07)70270-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"1913_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1529-8019.2012.01496.x","volume":"25","author":"RA Gordon","year":"2012","unstructured":"Gordon RA, Mays R, Sambrano B, Mayo T, Lapolla W (2012) Antibiotics used in nonbacterial dermatologic conditions. Dermatol Ther 25(1):38\u201354. \n                    https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01496.x","journal-title":"Dermatol Ther"},{"issue":"4","key":"1913_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/pch\/3.4.281","volume":"3","author":"M Greenwald","year":"1998","unstructured":"Greenwald M (1998) Re: the new macrolide antibiotics: use them carefully. Paediatr Child Health 3(4):281\u2013282","journal-title":"Paediatr Child Health"},{"issue":"3","key":"1913_CR60","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"MO Griffin","year":"2010","unstructured":"Griffin MO, Fricovsky E, Ceballos G, Villarreal F (2010) Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299(3):C539\u2013C548. \n                    https:\/\/doi.org\/10.1152\/ajpcell.00047.2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"1913_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.phrs.2011.05.011","volume":"64","author":"Y Gu","year":"2011","unstructured":"Gu Y, Lee HM, Simon SR, Golub LM (2011) Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase. Pharmacol Res 64(6):595\u2013601. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2011.05.011","journal-title":"Pharmacol Res"},{"issue":"6","key":"1913_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1540-9740.2006.05991.x","volume":"5","author":"AK Gupta","year":"2006","unstructured":"Gupta AK, Gover MD, Abramovits W, Perlmutter A (2006) Solodyn (Minocycline HCl, USP) extended-release tablets. Skinmed 5(6):291\u2013292","journal-title":"Skinmed"},{"issue":"2","key":"1913_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/08959374980120010301","volume":"12","author":"R Hanemaaijer","year":"1998","unstructured":"Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM, van Hinsbergh VW (1998) Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 12(2):114\u2013118. \n                    https:\/\/doi.org\/10.1177\/08959374980120010301","journal-title":"Adv Dent Res"},{"key":"1913_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","volume":"909","author":"Y He","year":"2001","unstructured":"He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187\u2013193. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(01)02681-6","journal-title":"Brain Res"},{"issue":"4","key":"1913_CR65","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397. \n                    https:\/\/doi.org\/10.1016\/S1353-8020(11)70065-7","journal-title":"Lancet Neurol"},{"key":"1913_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.05.035","author":"TH Johnston","year":"2018","unstructured":"Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM (2018) Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Neuropharmacology. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.035\n                    \n                  )","journal-title":"Neuropharmacology"},{"issue":"3","key":"1913_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/156720107781023938","volume":"4","author":"J Jordan","year":"2007","unstructured":"Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N, Galindo MF (2007) Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr Drug Deliv 4(3):225\u2013231. \n                    https:\/\/doi.org\/10.2174\/156720107781023938","journal-title":"Curr Drug Deliv"},{"issue":"13","key":"1913_CR68","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","volume":"157","author":"N Joshi","year":"1997","unstructured":"Joshi N, Miller DQ (1997) Doxycycline revisited. Arch Intern Med 157(13):1421\u20131428. \n                    https:\/\/doi.org\/10.1001\/archinte.1997.00440340035003","journal-title":"Arch Intern Med"},{"key":"1913_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2478\/infl-2013-0002","volume":"2013","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen A, Salminen A, Kaarniranta K (2013) Inflammation as a target of minocycline: special interest in the regulation of inflammasome signaling. Inflammasome 2013:2\u201314. \n                    https:\/\/doi.org\/10.2478\/infl-2013-0002","journal-title":"Inflammasome"},{"issue":"8","key":"1913_CR70","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/cid\/cix013","volume":"64","author":"SP Keijmel","year":"2017","unstructured":"Keijmel SP, Delsing CE, Bleijenberg G, van der Meer JWM, Donders RT, Leclercq M et al (2017) Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure study): a randomized controlled trial. Clin Infect Dis 64(8):998\u20131005. \n                    https:\/\/doi.org\/10.1093\/cid\/cix013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1913_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0269881112467089","volume":"27","author":"WR Keller","year":"2013","unstructured":"Keller WR, Kum LM, Wehring HJ, Koola MM, Buchanan RW, Kelly DL (2013) A review of anti-inflammatory agents for symptoms of schizophrenia. J Psychopharmacol 27(4):337\u2013342. \n                    https:\/\/doi.org\/10.1177\/0269881112467089","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1913_CR72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","volume":"35","author":"DL Kelly","year":"2015","unstructured":"Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM et al (2015) Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms. J Clin Psychopharmacol 35(4):374\u2013381. \n                    https:\/\/doi.org\/10.1097\/JCP.0000000000000345","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1913_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","volume":"196","author":"H-S Kim","year":"2009","unstructured":"Kim H-S, Suh Y-H (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196(2):168\u2013179. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2008.09.040","journal-title":"Behav Brain Res"},{"issue":"5","key":"1913_CR74","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1471-4159.2010.06834.x","volume":"114","author":"LM Kosloski","year":"2010","unstructured":"Kosloski LM, Ha DM, Stone DK, Hutter JAL, Pichler MR, Reynolds AD, Gendelman HE, Mosley RL (2010) Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases. J Neurochem 114(5):1261\u20131276. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06834.x","journal-title":"J Neurochem"},{"key":"1913_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A (2013) The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 28:311\u2013318. \n                    https:\/\/doi.org\/10.1002\/mds.25292","journal-title":"Mov Disord"},{"issue":"3","key":"1913_CR76","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","volume":"94","author":"RL Kraus","year":"2005","unstructured":"Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94(3):819\u2013827. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03219.x","journal-title":"J Neurochem"},{"issue":"10","key":"1913_CR77","first-page":"1502","volume":"19","author":"P Langevitz","year":"1992","unstructured":"Langevitz P, Bank I, Zemer D, Book M, Pras M (1992) Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol 19(10):1502\u20131504","journal-title":"J Rheumatol"},{"issue":"7","key":"1913_CR78","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/glia.22496","volume":"61","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M, Vozari RR, St\u00fchmer W, Bel ED (2013) Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia 61(7):1084\u20131100. \n                    https:\/\/doi.org\/10.1002\/glia.22496","journal-title":"Glia"},{"issue":"4","key":"1913_CR79","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","volume":"4","author":"JK Lee","year":"2009","unstructured":"Lee JK, Tran T, Tansey MG (2009) Neuroinflammation in Parkinson\u2019s disease. J Neuroimmune Pharmacol 4(4):419\u2013429. \n                    https:\/\/doi.org\/10.1007\/s11481-009-9176-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"1913_CR80","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/35093537","volume":"2","author":"M Lewandoski","year":"2001","unstructured":"Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Gene 2:743\u2013755. \n                    https:\/\/doi.org\/10.1038\/35093537","journal-title":"Nat Rev Gene"},{"issue":"1","key":"1913_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1212\/WNL.62.1_suppl_1.S9","volume":"62","author":"PA LeWitt","year":"2004","unstructured":"LeWitt PA, Nyholm D (2004) New developments in levodopa therapy. Neurology 62(1):9\u201316. \n                    https:\/\/doi.org\/10.1212\/WNL.62.1_suppl_1.S9","journal-title":"Neurology"},{"key":"1913_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fimmu.2017.00271","volume":"8","author":"C Lin","year":"2017","unstructured":"Lin C, Zhang J (2017) Inflammasomes in inflammation-induced cancer. Front Immunol 8:271. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00271","journal-title":"Front Immunol"},{"issue":"11","key":"1913_CR83","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00018-007-6516-1","volume":"64","author":"A Lleo","year":"2007","unstructured":"Lleo A, Galea E, Sastre M (2007) Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol Life Sci 64(11):1403\u20131418. \n                    https:\/\/doi.org\/10.1007\/s00018-007-6516-1","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1913_CR84","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A et al (2004) A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease. J Am Geriatr Soc 52(3):381\u2013387. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52109.x","journal-title":"J Am Geriatr Soc"},{"key":"1913_CR85","doi-asserted-by":"publisher","first-page":"495091","DOI":"10.1155\/2014\/495091","volume":"2014","author":"P Maiti","year":"2014","unstructured":"Maiti P, Manna J, Veleri S, Frautschy S (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014:495091. \n                    https:\/\/doi.org\/10.1155\/2014\/495091","journal-title":"Biomed Res Int"},{"issue":"18","key":"1913_CR86","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1093\/nar\/gni146","volume":"33","author":"J Mao","year":"2005","unstructured":"Mao J, Barrow J, McMahon J, Vaughan J, McMahon AP (2005) An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo. Nucleic Acids Res 33(18):e155. \n                    https:\/\/doi.org\/10.1093\/nar\/gni146","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1913_CR87","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","volume":"110","author":"L Marinova-Mutafchieva","year":"2009","unstructured":"Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT (2009) Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease. J Neurochem 110(3):966\u2013975. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06189.x","journal-title":"J Neurochem"},{"key":"1913_CR88","first-page":"19","volume-title":"Antibiotics and their complexes","author":"RB Martin","year":"1985","unstructured":"Martin RB (1985) Tetracyclines and daunorubicin in metal ions in biological systems. In: Sigel H (ed) Antibiotics and their complexes. Marcel Dekker, New York, pp 19\u201340"},{"key":"1913_CR89","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1196\/annals.1317.053","volume":"1070","author":"C Mart\u00ednez","year":"2006","unstructured":"Mart\u00ednez C, Arranz A, Juarranz Y, Abad C, Garc\u00eda-G\u00f3mez M, Rosignoli F, Leceta J, Gomariz RP (2006) PAC1 receptor: emerging target for septic shock therapy. Ann N Y Acad Sci 1070:405\u2013410. \n                    https:\/\/doi.org\/10.1196\/annals.1317.053","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1913_CR90","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23(4):474\u2013483","journal-title":"Mov Disord"},{"issue":"5","key":"1913_CR91","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","volume":"28","author":"DW Molloy","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q, Guyatt G (2013) A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial. Int J Geriatr Psychiatry 28(5):463\u2013470. \n                    https:\/\/doi.org\/10.1002\/gps.3846","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1913_CR92","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1476-9255-9-31","volume":"9","author":"A Moon","year":"2012","unstructured":"Moon A, Gil S, Gill SE, Chen P, Matute-Bello G (2012) Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide. J Inflamm 9(1):31. \n                    https:\/\/doi.org\/10.1186\/1476-9255-9-31","journal-title":"J Inflamm"},{"key":"1913_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/08959374980120011901","volume":"12","author":"ML Nelson","year":"1998","unstructured":"Nelson ML (1998) Chemical and biological dynamics of tetracyclines. Adv Dent Res 12:5\u201311. \n                    https:\/\/doi.org\/10.1177\/08959374980120011901","journal-title":"Adv Dent Res"},{"key":"1913_CR94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","volume":"1241","author":"ML Nelson","year":"2011","unstructured":"Nelson ML, Levy ST (2011) The history of Tetracyclines Ann. N Y Acad Sci 1241:17\u201332","journal-title":"N Y Acad Sci"},{"key":"1913_CR95","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03520.x","volume":"96","author":"M Nikodemova","year":"2006","unstructured":"Nikodemova M, Duncan ID, Watters JJ (2006) Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem 96:314\u2013323. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03520.x","journal-title":"J Neurochem"},{"issue":"5","key":"1913_CR96","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","volume":"66","author":"NINDS NET-PD Investigators","year":"2006","unstructured":"NINDS NET-PD Investigators (2006) A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 66(5):664\u2013671. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000201252.57661.e1","journal-title":"Neurology"},{"issue":"3","key":"1913_CR97","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1096\/fj.08-113795","volume":"23","author":"W Noble","year":"2009","unstructured":"Noble W, Garwood C, Stephenson J, Kinsey AM, Hanger DP, Anderton BH (2009a) Minocycline reduces the development of abnormal tau species in models of Alzheimer\u2019s disease. FASEB J 23(3):739\u2013750. \n                    https:\/\/doi.org\/10.1096\/fj.08-113795","journal-title":"FASEB J"},{"key":"1913_CR98","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4161\/pri.3.2.8820","volume":"3","author":"W Noble","year":"2009","unstructured":"Noble W, Garwood CJ, Hanger DP (2009b) Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding. Prion 3:78\u201383. \n                    https:\/\/doi.org\/10.4161\/pri.3.2.8820","journal-title":"Prion"},{"issue":"5","key":"1913_CR99","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s002960050030","volume":"17","author":"D Nordstr\u00f6m","year":"1998","unstructured":"Nordstr\u00f6m D, Lindy O, Lauhio A, Sorsa T, Santavirta S, Konttinen YT (1998) Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 17(5):175\u2013180","journal-title":"Rheumatol Int"},{"issue":"17","key":"1913_CR101","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/mds.21675","volume":"22","author":"CW Olanow","year":"2007","unstructured":"Olanow CW (2007) The pathogenesis of cell death in Parkinson\u2019s disease. Mov Disord 22(17):335\u2013342. \n                    https:\/\/doi.org\/10.1002\/mds.21675","journal-title":"Mov Disord"},{"issue":"3","key":"1913_CR102","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mds.22061","volume":"23","author":"CW Olanow","year":"2008","unstructured":"Olanow CW (2008) Levodopa\/dopamine replacement strategies in Parkinson\u2019s disease\u2013future directions. Mov Disord 23(3):613\u2013622. \n                    https:\/\/doi.org\/10.1002\/mds.22061","journal-title":"Mov Disord"},{"issue":"3","key":"1913_CR103","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/187152709788680689","volume":"8","author":"D Orsucci","year":"2009","unstructured":"Orsucci D, Calsolaro V, Mancuso M, Siciliano G (2009) Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets 8(3):222\u2013231. \n                    https:\/\/doi.org\/10.2174\/187152709788680689","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"1913_CR104","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bph.14081","volume":"175","author":"A Papapetropoulos","year":"2018","unstructured":"Papapetropoulos A, Szabo C (2018) Inventing new therapies without reinventing the wheel: the power of drug repurposing. Br J Pharmacol 175(2):165\u2013167. \n                    https:\/\/doi.org\/10.1111\/bph.14081","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1913_CR105","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2014.391","volume":"71","author":"SA Parashos","year":"2014","unstructured":"Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM (2014) Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson disease (NET-PD) experience. JAMA Neurol 71(6):710\u2013716. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2014.391","journal-title":"JAMA Neurol"},{"issue":"1","key":"1913_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1866-1955-5-9","volume":"5","author":"CA Pardo","year":"2013","unstructured":"Pardo CA, Buckley A, Thurm A, Lee LC, Azhagiri A, Neville DM, Swedo SE (2013) A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord 5(1):9. \n                    https:\/\/doi.org\/10.1186\/1866-1955-5-9","journal-title":"J Neurodev Disord"},{"key":"1913_CR107","doi-asserted-by":"publisher","first-page":"262","DOI":"10.14219\/jada.archive.2011.0165","volume":"142","author":"JB Payne","year":"2011","unstructured":"Payne JB, Golub LM, Stoner JA, Lee HM, Reinhardt RA, Sorsa T, Slepian MJ (2011) The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial. J Am Dent Assoc 142:262\u2013273. \n                    https:\/\/doi.org\/10.14219\/jada.archive.2011.0165","journal-title":"J Am Dent Assoc"},{"issue":"45","key":"1913_CR108","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.1523\/JNEUROSCI.3447-06.2006","volume":"26","author":"J Peng","year":"2006","unstructured":"Peng J, Xie L, Stevenson FF, Melov S, Di Monte DA, Andersen JK (2006) Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration. J Neurosci 26(45):11644\u201311651. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3447-06.2006","journal-title":"J Neurosci"},{"issue":"9","key":"1913_CR109","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eimc.2009.10.002","volume":"21","author":"E P\u00e9rez-Trallero","year":"2003","unstructured":"P\u00e9rez-Trallero E, Iglesias L (2003) Tetracyclines, sulfonamides and metronidazole. Enferm Infecc Microbiol Clin 21(9):520\u2013528. \n                    https:\/\/doi.org\/10.1016\/j.eimc.2009.10.002","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"1913_CR110","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1021\/jp055364y","volume":"110","author":"JM Plane","year":"2006","unstructured":"Plane JM, Joseph DM, Allan BJ, Ashworth SH, Francisco JS (2006) An experimental and theoretical study of the reactions OIO + NO and OIO + OH. J Phys Chem A 110(1):93\u2013100. \n                    https:\/\/doi.org\/10.1021\/jp055364y","journal-title":"J Phys Chem A"},{"issue":"12","key":"1913_CR111","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1001\/archneurol.2010.191","volume":"67","author":"JM Plane","year":"2010","unstructured":"Plane JM, Shen Y, Pleasure DE, Deng W (2010) Prospects for minocycline neuroprotection. Arch Neurol 67(12):1442\u20131448. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.191","journal-title":"Arch Neurol"},{"issue":"4","key":"1913_CR112","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10072-005-0474-x","volume":"26","author":"FE Pontieri","year":"2005","unstructured":"Pontieri FE, Ricci A, Pellicano C, Benincasa D, Buttarelli FR (2005) Minocycline in amyotrophic lateral sclerosis: a pilot study. Neurol Sci 26(4):285\u2013287. \n                    https:\/\/doi.org\/10.1007\/s10072-005-0474-x","journal-title":"Neurol Sci"},{"issue":"6","key":"1913_CR113","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0006-2952(92)90381-R","volume":"44","author":"W Pruzanski","year":"1992","unstructured":"Pruzanski W, Greenwald RA, Street IP, Laliberte F, Stefanski E, Vadas P (1992) Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 44(6):1165\u20131170. \n                    https:\/\/doi.org\/10.1016\/0006-2952(92)90381-R","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1913_CR114","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainres.2006.03.104","volume":"1093","author":"EM Quintero","year":"2006","unstructured":"Quintero EM, Willis L, Singleton R, Harris N, Huang P, Bhat N, Granholm AC (2006) Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson\u2019s disease. Brain Res 1093(1):198\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2006.03.104","journal-title":"Brain Res"},{"issue":"1","key":"1913_CR115","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1017\/S0317167100009690","volume":"37","author":"K Radad","year":"2010","unstructured":"Radad K, Moldzio R, Rausch WD (2010) Minocycline protects dopaminergic neurons against long-term rotenone toxicity. Can J Neurol Sci 37(1):81\u201385. \n                    https:\/\/doi.org\/10.1017\/S0317167100009690","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"1913_CR116","doi-asserted-by":"publisher","first-page":"L56","DOI":"10.1186\/2193-1801-4-S1-L56","volume":"4","author":"D Reglodi","year":"2015","unstructured":"Reglodi D, Maasz G, Pirger Z, Rivnyak A, Balogh D, Jungling A, Fulop B, Mark L et al (2015) Neurochemical changes in different brain regions induced by PACAP\u2014relations to neuroprotection. Springerplus 4(1):L56. \n                    https:\/\/doi.org\/10.1186\/2193-1801-4-S1-L56","journal-title":"Springerplus"},{"key":"1913_CR117","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","volume":"155","author":"D Reglodi","year":"2017","unstructured":"Reglodi D, Renaud J, Tamas A, Tizabi Y, Soc\u00edas SB, Del-Bel E, Raisman-Vozari R (2017) Novel tactics for neuroprotection in Parkinson\u2019s disease: role of antibiotics, polyphenols and neuropeptides. Prog Neurobiol 155:120\u2013148. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2015.10.004","journal-title":"Prog Neurobiol"},{"key":"1913_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1749-6632.1994.tb24733.x","volume":"732","author":"BR Rifkin","year":"1994","unstructured":"Rifkin BR, Vernillo AT, Golub LM, Ramamurthy NS (1994) Modulation of bone resorption by tetracyclines. Ann NY Acad Sci 732:165\u2013180. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1994.tb24733.x","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"1913_CR119","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.arcmed.2017.08.005","volume":"48","author":"M Rodr\u00edguez-Violante","year":"2017","unstructured":"Rodr\u00edguez-Violante M, Zer\u00f3n-Mart\u00ednez R, Cervantes-Arriaga A, Corona T (2017) Who can diagnose Parkinson\u2019s disease first? Role of pre-motor symptoms. Arch Med Res 48(3):221\u2013227. \n                    https:\/\/doi.org\/10.1016\/j.arcmed.2017.08.005","journal-title":"Arch Med Res"},{"key":"1913_CR120","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE et al (2005) \u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73\u201377","journal-title":"Nature"},{"issue":"17","key":"1913_CR121","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1111\/bph.12727","volume":"171","author":"C Ruzza","year":"2014","unstructured":"Ruzza C, Rizzi A, Malfacini D, Cerlesi MC, Ferrari F, Marzola E, Ambrosio C, Gro C et al (2014) Pharmacological characterization of tachykinin tetrabranched derivatives. Br J Pharmacol 171(17):4125\u20134137. \n                    https:\/\/doi.org\/10.1111\/bph.12727","journal-title":"Br J Pharmacol"},{"key":"1913_CR122","unstructured":"Sande MA, Mandell GL (1985) Antimicrobial agents, tetracyclines. chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Goodman and Gilman\u2019s (ed) The pharmacological basis of therapeutics, 7th edn. McGraw-Hill, New York"},{"issue":"4","key":"1913_CR123","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"FV Santa-Cec\u00edlia","year":"2016","unstructured":"Santa-Cec\u00edlia FV, Socias B, Ouidja MO, Sepulveda-Diaz JE, Acu\u00f1a L, Silva RL, Michel PP, Del-Bel E, Cunha TM, Raisman-Vozari R (2016) Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox Res 29(4):447\u2013459. \n                    https:\/\/doi.org\/10.1007\/s12640-015-9592-2","journal-title":"Neurotox Res"},{"key":"1913_CR124","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R (2006) Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258\u2013265. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2005.10.004","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1913_CR125","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/jnnp.2004.035980","volume":"76","author":"AH Schapira","year":"2005","unstructured":"Schapira AH (2005) Present and future drug treatment for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 76(11):1472\u20131478. \n                    https:\/\/doi.org\/10.1136\/jnnp.2004.035980","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1913_CR126","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd2087","volume":"5","author":"AH Schapira","year":"2006","unstructured":"Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E et al (2006) Novel pharmacological targets for the treatment of Parkinson\u2019s disease. Nat Rev Drug Discov 5(10):845\u2013854. \n                    https:\/\/doi.org\/10.1038\/nrd2087","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1913_CR127","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/138161211795049679","volume":"17","author":"T Seaborn","year":"2011","unstructured":"Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17(3):204\u2013214. \n                    https:\/\/doi.org\/10.2174\/138161211795049679","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1913_CR128","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/archderm.139.4.459","volume":"139","author":"R Skidmore","year":"2003","unstructured":"Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J, Powala C, Ashley R (2003) Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 139(4):459\u2013464. \n                    https:\/\/doi.org\/10.1001\/archderm.139.4.459","journal-title":"Arch Dermatol"},{"issue":"9","key":"1913_CR129","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1089\/hum.2005.16.1037","volume":"16","author":"JR Smith","year":"2005","unstructured":"Smith JR, Verwaerde C, Rolling F, Naud MC, Delanoye A, Thillaye-Goldenberg B, Apparailly F, De Kozak Y (2005) Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 16(9):1037\u20131046. \n                    https:\/\/doi.org\/10.1089\/hum.2005.16.1037","journal-title":"Hum Gene Ther"},{"issue":"5","key":"1913_CR130","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/ar3491","volume":"13","author":"CJ Smith","year":"2011","unstructured":"Smith CJ, Sayles H, Mikuls TR, Michaud K (2011) Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects. Arthritis Res Ther 13(5):R168. \n                    https:\/\/doi.org\/10.1186\/ar3491","journal-title":"Arthritis Res Ther"},{"key":"1913_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2017.12.002","author":"SB Socias","year":"2018","unstructured":"Socias SB, Gonz\u00e1lez-Liz\u00e1rraga F, Avila CL, Vera C, Acu\u00f1a L, Sepulveda-Diaz JE, Del-Bel E, Raisman-Vozari R, Chehin RN (2018) Exploiting the therapeutic potential of ready-to-use drugs: repurposing antibiotics against amyloid aggregation in neurodegenerative diseases. Prog Neurobiol. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2017.12.002","journal-title":"Prog Neurobiol"},{"issue":"3","key":"1913_CR132","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O\u2019Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96(3):706\u2013718. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03566.x","journal-title":"J Neurochem"},{"key":"1913_CR133","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuropharm.2013.04.059","volume":"73","author":"ML Stock","year":"2013","unstructured":"Stock ML, Fiedler KJ, Acharya S, Lange JK, Mlynarczyk GS, Anderson SJ, McCormack GR, Kanuri SH, Kondru NC, Brewer MT, Carlson SA (2013) Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities. Neuropharmacology 73:174\u2013182","journal-title":"Neuropharmacology"},{"issue":"15","key":"1913_CR134","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1021\/jm400161p","volume":"56","author":"T Stoilova","year":"2013","unstructured":"Stoilova T, Colombo L, Forloni G, Tagliavini F, Salmona M (2013) A new face for old antibiotics: tetracyclines in treatment of amyloidoses. J Med Chem 56(15):5987\u20136006. \n                    https:\/\/doi.org\/10.1021\/jm400161p","journal-title":"J Med Chem"},{"issue":"41","key":"1913_CR135","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1523\/JNEUROSCI.5069-13.2014","volume":"34","author":"M Subramaniam","year":"2014","unstructured":"Subramaniam M, Althof D, Gispert S, Schwenk J, Auburger G, Kulik A, Fakler B, Roeper J (2014) Mutant \u03b1-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels. J Neurosci 34(41):13586\u201313599. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5069-13.2014","journal-title":"J Neurosci"},{"key":"1913_CR136","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnins.2013.00131","volume":"7","author":"S Sultan","year":"2013","unstructured":"Sultan S, Gebara E, Toni N (2013) Doxycycline increases neurogenesis and reduces microglia in the adult hippocampus. Front Neurosci 7:131. \n                    https:\/\/doi.org\/10.3389\/fnins.2013.00131","journal-title":"Front Neurosci"},{"issue":"4","key":"1913_CR137","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4103\/0972-124X.149934","volume":"19","author":"DN Swamy","year":"2015","unstructured":"Swamy DN, Sanivarapu S, Moogla S, Kapalavai V (2015) Chemically modified tetracyclines: the novel host modulating agents. J Indian Soc Periodontol 19(4):370\u2013374. \n                    https:\/\/doi.org\/10.4103\/0972-124X.149934","journal-title":"J Indian Soc Periodontol"},{"key":"1913_CR138","first-page":"672","volume":"51","author":"RJ Tamargo","year":"1991","unstructured":"Tamargo RJ, Bok RA, Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51:672\u2013675","journal-title":"Cancer Res"},{"issue":"3","key":"1913_CR139","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37(3):510\u2013518. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1913_CR140","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/1742-6723.12150","volume":"25","author":"N Taylor","year":"2013","unstructured":"Taylor N (2013) Direct current cardioversion causing ventricular fibrillation in Wolff-Parkinson-White syndrome. Emerg Med Australas 25(6):612\u2013614. \n                    https:\/\/doi.org\/10.1111\/1742-6723.12150","journal-title":"Emerg Med Australas"},{"issue":"3","key":"1913_CR141","first-page":"443","volume":"35","author":"YH Thong","year":"1979","unstructured":"Thong YH, Ferrante A (1979) Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 35(3):443\u2013446","journal-title":"Clin Exp Immunol"},{"key":"1913_CR142","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","volume":"166","author":"TM Tikka","year":"2001","unstructured":"Tikka TM, Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527\u20137533. \n                    https:\/\/doi.org\/10.4049\/jimmunol.166.12.7527","journal-title":"J Immunol"},{"issue":"12","key":"1913_CR143","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","volume":"271","author":"T Tomiyama","year":"1996","unstructured":"Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, Endo N (1996) Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem 271(12):6839\u20136844","journal-title":"J Biol Chem"},{"issue":"7","key":"1913_CR144","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/mds.20856","volume":"21","author":"TG Ton","year":"2006","unstructured":"Ton TG, Heckbert SR, Longstreth WT Jr, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H (2006) Nonsteroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease. Mov Disord 21(7):964\u2013969. \n                    https:\/\/doi.org\/10.1002\/mds.20856","journal-title":"Mov Disord"},{"key":"1913_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","volume":"88","author":"KU Tufekci","year":"2012","unstructured":"Tufekci KU, Meuwissen R, Genc S, Genc K (2012) Inflammation in Parkinson\u2019s disease. Adv Protein Chem Struct Biol 88:69\u2013132. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-398314-5.00004-0","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"2","key":"1913_CR146","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-010-1061-x","volume":"342","author":"B Wachter","year":"2010","unstructured":"Wachter B, Sch\u00fcrger S, Rolinger J, von Ameln-Mayerhofer A, Berg D, Wagner HJ, Kueppers E (2010) Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes. Cell Tissue Res 342(2):147\u2013160. \n                    https:\/\/doi.org\/10.1007\/s00441-010-1061-x","journal-title":"Cell Tissue Res"},{"issue":"4","key":"1913_CR147","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3969\/j.issn.1672-7347.2010.04.012","volume":"35","author":"X Wang","year":"2010","unstructured":"Wang X, Cai H, Yan X, Ye Z (2010) Effect of different tidal volume ventilation on apoptosis and the expression of Bax and Bcl-2 in rat lungs. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(4):351\u2013357. \n                    https:\/\/doi.org\/10.3969\/j.issn.1672-7347.2010.04.012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"1913_CR148","doi-asserted-by":"publisher","first-page":"45103","DOI":"10.1038\/srep45103","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang W, Sidoli S, Zhang W, Wang Q, Wang L, Jensen ON, Guo L, Zhao X, Zheng L (2017) Abnormal levels of histone methylation in the retinas of diabetic rats are reversed by minocycline treatment. Sci Rep 7:45103. \n                    https:\/\/doi.org\/10.1038\/srep45103","journal-title":"Sci Rep"},{"key":"1913_CR149","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/10715769709097783","volume":"26","author":"M Whiteman","year":"1997","unstructured":"Whiteman M, Halliwell B (1997) Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Radic Res 26:49\u201356","journal-title":"Free Radic Res"},{"issue":"2","key":"1913_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313. \n                    https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nat Med"},{"key":"1913_CR151","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/ejn.12269","volume":"38","author":"MM Worlitzer","year":"2013","unstructured":"Worlitzer MM, Viel T, Jacobs AH, Schwamborn JC (2013) The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflamation. Eur J Neurosci 38:2684\u20132692. \n                    https:\/\/doi.org\/10.1111\/ejn.12269","journal-title":"Eur J Neurosci"},{"key":"1913_CR152","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763\u20131771","journal-title":"J Neurosci"},{"issue":"2","key":"1913_CR153","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.10709","volume":"74","author":"L Yang","year":"2003","unstructured":"Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74(2):278\u2013285. \n                    https:\/\/doi.org\/10.1002\/jnr.10709","journal-title":"J Neurosci Res"},{"key":"1913_CR154","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","volume":"3","author":"VW Yong","year":"2004","unstructured":"Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM (2004) The promise of minocycline in neurology. Lancet Neurol. 3, 744\u2013751. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(04)00937-8","journal-title":"Lancet Neurol"},{"key":"1913_CR155","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrjanheikki","year":"1998","unstructured":"Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769\u201315774","journal-title":"Proc Natl Acad Sci USA"},{"key":"1913_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2015.11.032","volume":"103","author":"R Yu","year":"2016","unstructured":"Yu R, Zheng L, Cui Y, Zhang H, Ye H (2016) Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1. Neuropharmacology 103:1\u201315. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.032","journal-title":"Neuropharmacology"},{"issue":"2","key":"1913_CR157","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ana.10476","volume":"53","author":"W Zhang","year":"2003","unstructured":"Zhang W, Narayanan M, Friedlander RM (2003) Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann Neurol 53(2):267\u2013270. \n                    https:\/\/doi.org\/10.1002\/ana.10476","journal-title":"Ann Neurol"},{"issue":"18","key":"1913_CR158","first-page":"3468","volume":"19","author":"GB Zhang","year":"2015","unstructured":"Zhang GB, Feng YH, Wang PQ, Song JH, Wang P, Wang SA (2015) A study on the protective role of doxycycline upon dopaminergic neuron of LPS-PD rat model rat. Eur Rev Med Pharmacol Sci 19(18):3468\u20133474","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1913-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1913-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T23:20:52Z","timestamp":1565738452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1913-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":156,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1913-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}